The role of the transferrin-transferrin-receptor system in drug delivery and targeting

Trends in Pharmacological Sciences

Volumn 23, Issue 5, 2002, Pages 206-209

  Li, Hongyan ^a   Sun, Hongzhe ^b   Qian, Zhong Ming ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIULCER AGENT; BISMUTH; BRAIN DERIVED NEUROTROPHIC FACTOR; CHLOROQUINE; CRM 107; DAUNORUBICIN; DIPHTHERIA TOXIN; DOXORUBICIN; DRUG CARRIER; IMMUNOLIPOSOME; MACROGOL 2000; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX 26; TITANIUM; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN; CANCER CELL; CANCER THERAPY; CELL PROLIFERATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; GENE DELIVERY SYSTEM; HUMAN; MALARIA; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STROKE; ULCER;

EID: 0036570288     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(02)01989-2     Document Type: Review

References (30)

1. Drug delivery and targeting
2. Ligand-receptor-mediated drug delivery: An emerging paradigm in cellular drug targeting
3. Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
4. Mechanisms of iron uptake by mammalian cells
5. Iron homeostasis: Insight from genetics and animal models
6. Transferrin as a metal ion mediator
7. IV-protein complex: Potential relevance to anticancer activity of titanocenes
8. IV uptake and release by human serum transferrin by cancer cells: Understanding the mechanism of action of the anticancer drug titanocene dichloride
9. III-lactoferrin by intestinal cells
10. Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma
11. Transferrin as a targeting ligand for liposomes and anticancer drugs
12. Tumor regression with regional distribution of the targeted toxin Tf-CRM107 in patients with malignant brain tumors
13. Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107
14. Transferrin trojan horses as a rational approach for the biological delivery of therapeutic peptide domains
15. Human gene therapy
16. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes
17. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery
18. Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin
19. Brain iron transport and neurodegeneration
20. Delivery of peptides and proteins through the blood-brain barrier
21. Transferrin receptor on endothelium of brain capillaries
22. 125I] transferrin through the rat blood-brain barrier in vivo
23. Antisense imaging of gene expression in the brain in vivo
24. Vector-mediated delivery of a polyamide ('peptide') nucleic acid analogue through the blood-brain barrier in vivo
25. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to blood-brain barrier drug targeting system
26. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin
27. Brain drug delivery of small molecules using immunoliposomes
28. Noninvasive gene targeting to the brain
29. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes
30. Brain-specific expression of an exogenous gene after i.v. administration